Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The quiet drug revolution.

M Graham

    Medical Economics
    |January 26, 1991
    PubMed
    Summary

    Grave patients can now access breakthrough medicines faster due to a recent regulatory change. This expedited pathway significantly reduces the time for new drug approvals for critical conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Change in infection sites of invasive and severe deep disease due to Streptococcus pyogenes during the 2022-2023 surge: A retrospective study in Melbourne, Australia.

    Infection, disease & health·2026
    Same author

    Cryptococcal laryngitis in an immunocompetent asthmatic patient using inhaled corticosteroids.

    Medical mycology case reports·2023
    Same author

    Spontaneous maternal coagulopathy in COVID-19.

    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2022
    Same author

    Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

    The European physical journal. C, Particles and fields·2021
    Same author

    Sugar prevalence in Aedes albopictus differs by habitat, sex and time of day on Masig Island, Torres Strait, Australia.

    Parasites & vectors·2021
    Same author

    Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection.

    Pathology·2021

    Area of Science:

    • Medical Regulatory Affairs
    • Drug Development
    • Clinical Pharmacology

    Background:

    • Traditional new product approval processes are lengthy, often spanning a decade.
    • Patients with severe illnesses face significant delays in accessing potentially life-saving treatments.

    Purpose of the Study:

    • To highlight a significant, yet under-recognized, change in regulatory pathways.
    • To explain how this change accelerates access to breakthrough medicines for critically ill individuals.

    Main Methods:

    • Analysis of regulatory policy changes impacting drug approval timelines.
    • Review of expedited pathways for critical care medications.

    Main Results:

    • A notable shift in regulatory procedures allows for faster approval of new medical products.
    • Critically ill patients can now access breakthrough medicines much more rapidly than before.

    Conclusions:

    • The recent regulatory modification offers a faster route for new medicines to reach patients with grave conditions.
    • This change represents a crucial advancement in addressing unmet medical needs for the terminally ill.

    Related Experiment Videos